Disclosure under Insider Trading Regulations
Promoter Sanjiv Goyal disposed of 80,00,000 shares via gift, while Raman Goyal acquired the same amount, changing their holdings on 27 Nov 2025.
The disclosure relates to an off-market transfer of shares between related parties and is unlikely to significantly impact the company's operations or market value.
The announcement is a disclosure of shareholding changes due to a gift transaction between promoters, with no inherent positive or negative implications.
* Mr. Sanjiv Goyal, a promoter and Chairman & Managing Director, disposed of 80,00,000 equity shares by way of gift to his wife, reducing his holding from 24.90% (5,58,45,600 shares) to 21.33% (4,78,45,600 shares) on 27 November 2025 through an off-market transaction. * Ms. Raman Goyal, belonging to the promoter group, acquired 80,00,000 equity shares by way of gift, increasing her holding from 0.55% (12,38,448 shares) to 4.12% (92,38,448 shares) on 27 November 2025 through an off-market transaction.
What to do with a filing like this
Nectar Lifesciences Limited filed this with the NSE as a statutory disclosure, categorised under insider trading. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Nectar Lifesciences Limited. Read the original for the full detail.